Featured
-
-
Outlook |
Advances in highly targeted radiation treatment for cancer have ignited interest in a once obscure field
Therapies that treat while diagnosing — theranostics — can extend length of survival and improve the quality of life for some people with advance-stage cancer.
- Rachel Nuwer
-
News & Views |
Pollen problems: May brings dismay to a hay-fever sufferer in 1874
A book on everyday biology that appeals to non-specialists and specialists alike, and a trek through hay fields causes one Nature reader to experience relentless ‘sneezings’, in the weekly dip into Nature’s archive.
-
News |
Autistic people three times more likely to develop Parkinson’s-like symptoms
Largest study of its kind also finds increased risk in older adults with a range of intellectual disabilities.
- Miryam Naddaf
-
News |
Ozempic keeps wowing: trial data show benefits for kidney disease
Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with diabetes.
- Rachel Fairbank
-
News & Views |
Neural pathways for reward and relief promote fentanyl addiction
Neuroscientists find that two distinct neural pathways are responsible for the addictive properties of the opioid fentanyl: one mediates reward, the other promotes the seeking of relief from symptoms of withdrawal.
- Markus Heilig
- & Michele Petrella
-
Article |
Covalent targeted radioligands potentiate radionuclide therapy
Radiopharmaceuticals engineered with click chemistry to selectively bind to tumour-specific proteins can be used to successfully target tumour cells, boosting the pharmacokinetics of radionuclide therapy and improving tumour regression.
- Xi-Yang Cui
- , Zhu Li
- & Zhibo Liu
-
Article
| Open AccessA whole-slide foundation model for digital pathology from real-world data
Prov-GigaPath, a whole-slide pathology foundation model pretrained on a large dataset containing around 1.3 billion pathology images, attains state-of-the-art performance in cancer classification and pathomics tasks.
- Hanwen Xu
- , Naoto Usuyama
- & Hoifung Poon
-
Correspondence |
Internet use and teen mental health: it’s about more than just screen time
- Linxiao Zhang
-
Correspondence |
Social-media influence on teen mental health goes beyond just cause and effect
- Michael A. Spikes
-
Clinical Briefing |
mRNA therapy is safe for treating the inherited metabolic condition propionic acidaemia
Propionic acidaemia is an inheirited metabolic condition caused by a lack of a liver enzyme, which leads to accumulation of toxic compounds. In a first-in-human trial, a therapeutic messenger RNA drug (mRNA-3927) led to restored enzyme activity, was well tolerated and showed a promising dose-dependent reduction of potentially life-threatening clinical events.
-
News |
Gut microbes linked to fatty diet drive tumour growth
Scientists know there is a link between obesity and some cancers. A study in mice and people suggests why that might be.
- Gillian Dohrn
-
News & Views |
Dual-action obesity drug rewires brain circuits for appetite
A two-in-one drug that modulates neural pathways involved in appetite and reward might prove to be more effective and longer lasting than current weight-loss drugs on the market.
- Tyler M. Cook
- & Darleen Sandoval
-
News |
Experimental obesity drug packs double punch to reduce weight
Test of weight-loss candidate in mice shows that there is still room for improvement in a burgeoning field.
- Asher Mullard
-
Article
| Open AccessGLP-1-directed NMDA receptor antagonism for obesity treatment
Unimolecular integration of NMDA receptor antagonism with GLP-1 receptor agonism effectively reverses obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease.
- Jonas Petersen
- , Mette Q. Ludwig
- & Christoffer Clemmensen
-
Correspondence |
Interpersonal therapy can be an effective tool against the devastating effects of loneliness
- Myrna M. Weissman
- & Jennifer J. Mootz
-
Outlook |
How ignorance and gender inequality thwart treatment of a widespread illness
Tens of millions of people have female genital schistosomiasis, a neglected tropical disease that few physicians have even heard of. Efforts are under way to move it out of obscurity and empower women and girls to access sexual and reproductive health care.
- Claire Ainsworth
-
News |
Bird flu in US cows: where will it end?
Scientists worry that the H5N1 strain of avian influenza will become endemic in cattle, which would aid its spread in people.
- Sara Reardon
-
Article
| Open AccessDiscovery of potent small-molecule inhibitors of lipoprotein(a) formation
Biochemical screening and optimization identify small molecules that inhibit the formation of lipoprotein(a), and these inhibitors reduce the levels of Lp(a) in several animal models, suggesting that they could provide a therapeutic option in humans.
- Nuria Diaz
- , Carlos Perez
- & Laura F. Michael
-
Article |
A meta-analysis on global change drivers and the risk of infectious disease
Reducing greenhouse gas emissions, managing ecosystem health, and preventing biological invasions and biodiversity loss could help to reduce the burden of plant, animal and human diseases, especially when coupled with improvements to social and economic determinants of health.
- Michael B. Mahon
- , Alexandra Sack
- & Jason R. Rohr
-
Nature Podcast |
Sex and gender discussions don't need to be toxic
The science of sex and gender is too often misinterpreted and weaponized. Now, three experts cut through the misinformation in search of a positive future for this long-neglected area of research
- Lucy Odling-Smee
- , Florence Ashley
- & Noah Baker
-
Comment |
Male–female comparisons are powerful in biomedical research — don’t abandon them
Binary sex studies have been denounced as too simplistic, but dropping them altogether would impede progress in a long-neglected area of biomedicine.
- Arthur P. Arnold
- , Sabra L. Klein
- & Jeffrey S. Mogil
-
News & Views |
Cells destroy donated mitochondria to build blood vessels
Organelles called mitochondria are transferred to blood-vessel-forming cells by support cells. Unexpectedly, these mitochondria are degraded, kick-starting the production of new ones and boosting vessel formation.
- Chantell S. Evans
-
Article
| Open AccessMultimodal decoding of human liver regeneration
Harnessing single-nucleus RNA sequencing and spatial profiling, this work dissects unanticipated aspects of human liver regeneration to uncover a novel migratory hepatocyte subpopulation mediating wound closure following acute liver injury.
- K. P. Matchett
- , J. R. Wilson-Kanamori
- & N. C. Henderson
-
Nature Podcast |
Audio long read: Why loneliness is bad for your health
New research is revealing the mechanisms linking loneliness and conditions like dementia, depression and cardiovascular disease.
- Saima May Sidik
- & Benjamin Thompson
-
News & Views |
Targeting RNA opens therapeutic avenues for Timothy syndrome
A therapeutic strategy that alters gene expression in a rare and severe neurodevelopmental condition has been tested in stem-cell-based models of the disease, and has been shown to correct genetic and cellular defects.
- Silvia Velasco
-
Article |
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
VVD-133214, a clinical-stage, covalent allosteric inhibitor of the helicase WRN, was well tolerated in mice and led to robust tumour regression in multiple microsatellite-instability-high colorectal cancer cell lines and patient-derived xenograft models.
- Kristen A. Baltgalvis
- , Kelsey N. Lamb
- & Todd M. Kinsella
-
Editorial |
Any plan to make smoking obsolete is the right step
The United Kingdom is correct to attempt to end the single largest preventable cause of illness and death, as was New Zealand before its government changed its mind.
-
Spotlight |
Deadly diseases and inflatable suits: how I found my niche in virology research
Virologist Hulda Jónsdóttir studies some of the world’s most pathogenic viruses at the Spiez Laboratory in Switzerland.
- Nikki Forrester
-
News Feature |
Obesity drugs aren’t always forever. What happens when you quit?
Many researchers think that Wegovy and Ozempic should be taken for life, but myriad factors can force people off them.
- McKenzie Prillaman
-
News Feature |
The rise of eco-anxiety: scientists wake up to the mental-health toll of climate change
Researchers want to unpick how climate change affects mental health around the world — from lives that are disrupted by catastrophic weather to people who are anxious about the future.
- Helen Pearson
-
Research Briefing |
Genetic risk variants lead to type 2 diabetes development through different pathways
The largest genome-wide association study for type 2 diabetes so far, which included several ancestry groups, led to the identification of eight clusters of genetic risk variants. The clusters capture different biological pathways that contribute to the disease, and some clusters are associated with vascular complications.
-
Nature Podcast |
The ‘ghost roads’ driving tropical deforestation
Researchers find that a huge number of roads that don’t appear on official maps, and the protein that could determine whether someone is left-handed.
- Nick Petrić Howe
- & Benjamin Thompson
-
Article |
Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids
Glucocorticoids reprogram the mitochondrial metabolism of macrophages, resulting in increased and sustained production of the anti-inflammatory metabolite itaconate and, as a consequence, inhibition of the inflammatory response.
- Jean-Philippe Auger
- , Max Zimmermann
- & Gerhard Krönke
-
Correspondence |
Use fines from EU social-media act to fund research on adolescent mental health
- Christian Montag
- & Benjamin Becker
-
Technology Feature |
‘Without these tools, I’d be lost’: how generative AI aids in accessibility
A rush to place barriers around the use of artificial intelligence in academia could disproportionately affect those who stand to benefit most.
- Amanda Heidt
-
News |
Diabetes drug slows development of Parkinson’s disease
The drug, which is in the same family as blockbuster weight-loss drugs such as Wegovy, slowed development of symptoms by a small but statistically significant amount.
- David Adam
-
News Feature |
Why loneliness is bad for your health
A lack of social interaction is linked to a higher risk of cardiovascular disease, dementia and more. Researchers are unpicking how the brain mediates these effects.
- Saima May Sidik
-
Article |
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia
Interim data from a clinical trial of mRNA-3927—an mRNA therapeutic for propionic acidaemia—provide early indications of the safety and efficacy of the treatment, and suggest that this approach might be applicable to other rare diseases.
- Dwight Koeberl
- , Andreas Schulze
- & Stephanie Grunewald
-
Article
| Open AccessAncestral allele of DNA polymerase gamma modifies antiviral tolerance
The POLG1 mutation p.W748S, which is associated with mitochondrial recessive ataxia syndrome, dampens innate immune responses by compromising mtDNA replisome stability, and this explains why a viral infection can trigger the development of the disease and contribute to its variable clinical manifestation.
- Yilin Kang
- , Jussi Hepojoki
- & Anu Suomalainen
-
News |
‘Mini liver’ will grow in person’s own lymph node in bold new trial
Biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time.
- Max Kozlov
-
Research Highlight |
Green space near home has an antidepressant effect
People who had the most vegetation near their residences were the least likely to report depression and anxiety.
-
Book Review |
The great rewiring: is social media really behind an epidemic of teenage mental illness?
The evidence is equivocal on whether screen time is to blame for rising levels of teen depression and anxiety — and rising hysteria could distract us from tackling the real causes.
- Candice L. Odgers
-
Outlook |
The future of at-home molecular testing
The COVID-19 pandemic showed what was possible for gene-based diagnostics. Now comes the true test – economics.
- Elie Dolgin
-
News |
Google AI could soon use a person’s cough to diagnose disease
Machine-learning system trained on millions of human audio clips shows promise for detecting COVID-19 and tuberculosis.
- Mariana Lenharo
-
News |
Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost
The treatment, called NexCAR19, raises hopes that this transformative class of medicine will become more readily available in low- and middle-income countries.
- Smriti Mallapaty
-
Nature Podcast |
AI hears hidden X factor in zebra finch love songs
Machine learning detects song differences too subtle for humans to hear, and physicists harness the computing power of the strange skyrmion.
- Nick Petrić Howe
- & Benjamin Thompson
-
News Explainer |
Ketamine is in the spotlight thanks to Elon Musk — but is it the right treatment for depression?
The entrepreneur endorses the drug, but researchers caution that it’s not to be taken lightly.
- David Adam
-
Article
| Open AccessTranscription–replication conflicts underlie sensitivity to PARP inhibitors
Poly(ADP-ribose) polymerase 1 (PARP1) functions together with TIMELESS and TIPIN to protect the replisome in early S phase from transcription–replication conflicts, and inhibiting PARP1 enzymatic activity may suffice for treatment efficacy in homologous recombination-deficient settings.
- Michalis Petropoulos
- , Angeliki Karamichali
- & Thanos D. Halazonetis
-
Browse broader subjects
Browse narrower subjects
- Cancer
- Cardiovascular diseases
- Dental diseases
- Endocrine system and metabolic diseases
- Eye diseases
- Gastrointestinal diseases
- Haematological diseases
- Immunological disorders
- Infectious diseases
- Kidney diseases
- Metabolic disorders
- Neurological disorders
- Nutrition disorders
- Oral diseases
- Psychiatric disorders
- Reproductive disorders
- Respiratory tract diseases
- Rheumatic diseases
- Skin diseases
- Trauma
- Urogenital diseases